Mohan S. Iyer
General Partner at IndieBio
San Francisco, California
Overview
Work Experience
General Partner
2021 - Current
Serving genius entrepreneurs to realize their vision of a better world by creating, scaling, and exiting meaningful new companies in human and planetary health
COO
2017 - 2021
Revolutionizing metabolic health | The first medical probiotic for people with type 2 diabetes to manage A1C, naturally.
Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.
Raised $121,200,000.00 from Alumni Ventures, Meritech Capital Partners, Khosla Ventures, Sequoia Capital and True Ventures.
Chief Business Officer
2012 - 2017
The first venture-backed microbiome company | The most important genome in your body may not be your own.
CFO
2011 - 2011
Chief Business Officer
2009 - 2011
Next-gen diagnostics from cutting-edge proteomics and metabolomics | The first commercial test to predict those at highest risk of converting to type 2 diabetes.
Tethys BioScience develops and commercializes biological markers for use in the diagnosis of metabolic diseases.
Raised $75,400,000.00 from Armentum Partners, Silicon Valley Bank and Oxford Finance LLC.
Managing Director, Merchant Banking
2006 - 2009
Strategic transactions (M&A and partnering) and selected financings for life science companies.
EVP, Corporate and Business Development
1997 - 2005
JV between GSK and Incyte | First mover in genomics-based diagnostics | The first and only diagnostic test for vulnerable plaque/risk of heart attack independent of cholesterol.
Senior Healthcare Consultant
1995 - 1997
Highly-focused and intensely-credible management consulting firm serving leading companies in pharma, biotech, diagnostics, and medical devices | Integrated into IBM Healthcare.
Senior Process Engineer
1986 - 1993
At the ground floor where it all began | Biochemical engineer helping to scale cGMP production of first 3 recombinant protein therapeutics that launched the biotechnology industry.